• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S1PR1 通过 p-STAT1/miR-30c-5 p/FOXA1 通路抑制肺腺癌进展。

S1PR1 suppresses lung adenocarcinoma progression through p-STAT1/miR-30c-5 p/FOXA1 pathway.

机构信息

Department of Health Management Center, The Third Xiangya Hospital of Central South University, Changsha, China.

Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.

出版信息

J Exp Clin Cancer Res. 2024 Nov 18;43(1):304. doi: 10.1186/s13046-024-03230-5.

DOI:10.1186/s13046-024-03230-5
PMID:39551792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11571582/
Abstract

BACKGROUND

Sphingosine-1-phosphate receptor 1 (S1PR1) is considered to be closely related to a variety of malignant tumors, but the role and mechanism of S1PR1 in lung adenocarcinoma are not fully understood. In this study, we aim to explore the role and downstream signaling pathways of S1PR1 in the malignant biological functions of lung adenocarcinoma (LUAD).

METHODS

Bioinformatics analysis, RT-qPCR, western blot and immunohistochemistry (IHC) were was used to investigate the expression of S1PR1 in LUAD. The prognosis of S1PR1 was also analyzed. CCK-8 assay, colony formation assay, scratch assay, transwell migration and invasion assay, cell adhesion assay were performed to examine the effect of S1PR1 on LUAD. RNA sequencing was employed to analyze the DEGs in LUAD cells overexpressing S1PR1. Enrichment pathway analysis using KEGG, GO, and GSEA was conducted to predict potential signaling pathways and downstream targets. chromatin immunoprecipitation (ChIP) and dual luciferase reporter assay were performed to verify the direct regulation between FOXA1 and the target genes. Then FOXA1 overexpression were performed to functional rescue experiments. miRNA-30c-5p was identified as a microRNA regulating FOXA1 by dual luciferase reporter assay. The downstream signaling pathways of S1PR1 was detected to clarify the specific pathways to regulates miR-30c-5p.

RESULTS

S1PR1 is significantly decreased in LUAD and is positively correlated with the prognosis. Overexpression of S1PR1 inhibits the proliferation, migration, invasion and adhesion function of LUAD cells by suppressing the expression of COL5A1, MMP1, and SERPINE1. FOXA1 is a key transcription factor regulating the expression of MMP1, COL5A1 and SERPINE1. S1PR1 inhibits the expression of FOXA1 through p-STAT1/miR-30c-5p, thereby suppressing the malignant function of LUAD cells.

CONCLUSIONS

The expression of S1PR1 is downregulated in LUAD, which is positively correlated with prognosis. S1PR1 regulates the malignant function of LUAD cells by inhibiting the expression of COL5A1, MMP1 and SERPINE1 through the p-STAT1/miR-30c-5p/FOXA1 signaling pathway.

摘要

背景

鞘氨醇-1-磷酸受体 1(S1PR1)被认为与多种恶性肿瘤密切相关,但 S1PR1 在肺腺癌中的作用和机制尚不完全清楚。本研究旨在探讨 S1PR1 在肺腺癌(LUAD)恶性生物学功能中的作用及其下游信号通路。

方法

采用生物信息学分析、RT-qPCR、Western blot 和免疫组织化学(IHC)检测 S1PR1 在 LUAD 中的表达。分析 S1PR1 的预后。采用 CCK-8 检测、集落形成实验、划痕实验、Transwell 迁移和侵袭实验、细胞黏附实验检测 S1PR1 对 LUAD 的影响。对过表达 S1PR1 的 LUAD 细胞进行 RNA 测序,分析差异表达基因(DEGs)。采用 KEGG、GO 和 GSEA 进行富集通路分析,预测潜在信号通路和下游靶点。采用染色质免疫沉淀(ChIP)和双荧光素酶报告基因检测验证 FOXA1 与靶基因的直接调控关系。然后进行 FOXA1 过表达的功能挽救实验。通过双荧光素酶报告基因检测鉴定出 miR-30c-5p 是调节 FOXA1 的 microRNA。检测 S1PR1 的下游信号通路,以阐明调节 miR-30c-5p 的特定通路。

结果

S1PR1 在 LUAD 中显著下调,与预后呈正相关。过表达 S1PR1 通过抑制 COL5A1、MMP1 和 SERPINE1 的表达,抑制 LUAD 细胞的增殖、迁移、侵袭和黏附功能。FOXA1 是调节 MMP1、COL5A1 和 SERPINE1 表达的关键转录因子。S1PR1 通过 p-STAT1/miR-30c-5p 抑制 FOXA1 的表达,从而抑制 LUAD 细胞的恶性功能。

结论

S1PR1 在 LUAD 中的表达下调,与预后呈正相关。S1PR1 通过抑制 COL5A1、MMP1 和 SERPINE1 的表达,通过 p-STAT1/miR-30c-5p/FOXA1 信号通路调节 LUAD 细胞的恶性功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/9d1573e7f033/13046_2024_3230_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/342a020e74c8/13046_2024_3230_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/ab1682c7493c/13046_2024_3230_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/378f701dbc85/13046_2024_3230_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/4976912b67c2/13046_2024_3230_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/598b2a82e280/13046_2024_3230_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/00fa0e9e9dcb/13046_2024_3230_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/780f501d6c35/13046_2024_3230_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/9d1573e7f033/13046_2024_3230_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/342a020e74c8/13046_2024_3230_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/ab1682c7493c/13046_2024_3230_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/378f701dbc85/13046_2024_3230_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/4976912b67c2/13046_2024_3230_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/598b2a82e280/13046_2024_3230_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/00fa0e9e9dcb/13046_2024_3230_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/780f501d6c35/13046_2024_3230_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cacf/11571582/9d1573e7f033/13046_2024_3230_Fig8_HTML.jpg

相似文献

1
S1PR1 suppresses lung adenocarcinoma progression through p-STAT1/miR-30c-5 p/FOXA1 pathway.S1PR1 通过 p-STAT1/miR-30c-5 p/FOXA1 通路抑制肺腺癌进展。
J Exp Clin Cancer Res. 2024 Nov 18;43(1):304. doi: 10.1186/s13046-024-03230-5.
2
miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.miR-139-5p 通过靶向 MAD2L1 抑制肺腺癌细胞的增殖、迁移和侵袭。
Comput Math Methods Med. 2020 Nov 4;2020:2953598. doi: 10.1155/2020/2953598. eCollection 2020.
3
Transcription Factor FOXA1 Facilitates Glycolysis and Proliferation of Lung Adenocarcinoma via Activation of TEX19.转录因子 FOXA1 通过激活 TEX19 促进肺腺癌的糖酵解和增殖。
Mol Biotechnol. 2024 Aug;66(8):2144-2154. doi: 10.1007/s12033-023-00848-2. Epub 2023 Aug 22.
4
FOXA1/UBE2T Inhibits CD8T Cell Activity by Inducing Mediates Glycolysis in Lung Adenocarcinoma.FOXA1/UBE2T 通过诱导肺腺癌中的糖酵解来抑制 CD8T 细胞的活性。
Front Biosci (Landmark Ed). 2024 Apr 1;29(4):134. doi: 10.31083/j.fbl2904134.
5
miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.miR-21-5p 通过靶向 WWC2 促进肺腺癌细胞的增殖、迁移和侵袭。
Cancer Biomark. 2020;28(4):549-559. doi: 10.3233/CBM-201489.
6
The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.新型环状 RNA circ-CAMK2A 通过调控 miR-615-5p/纤维连接蛋白 1 通路促进肺腺癌转移。
Cell Mol Biol Lett. 2019 Dec 26;24:72. doi: 10.1186/s11658-019-0198-1. eCollection 2019.
7
FOXA1-induced LINC00621 promotes lung adenocarcinoma progression via activating the TGF-β signaling pathway.FOXA1 诱导的 LINC00621 通过激活 TGF-β 信号通路促进肺腺癌进展。
Thorac Cancer. 2023 Jul;14(21):2026-2037. doi: 10.1111/1759-7714.14986. Epub 2023 Jun 5.
8
LINC01572 promotes the malignant progression of lung adenocarcinoma by modulating p53 mediated by miRNA-338-5p/TTK axis.LINC01572 通过调节 miRNA-338-5p/TTK 轴介导的 p53 促进肺腺癌的恶性进展。
J Pharm Pharmacol. 2024 Jul 5;76(7):873-883. doi: 10.1093/jpp/rgad128.
9
miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.miR-133b 通过靶向 CDCA8 抑制肺腺癌细胞的增殖、迁移和侵袭。
Pathol Res Pract. 2021 Jul;223:153459. doi: 10.1016/j.prp.2021.153459. Epub 2021 Apr 28.
10
CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.环状PRKCI通过靶向miR-219a-5p调控的CAMK1D来调节肺腺癌细胞的增殖、迁移和周期。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):1899-1909. doi: 10.26355/eurrev_202102_25085.

引用本文的文献

1
Sphingolipid metabolism dysregulation: A cause for lung cancer development, progression, and resistance to therapies.鞘脂代谢失调:肺癌发生、发展及治疗耐药的一个原因。
Chin Med J Pulm Crit Care Med. 2025 Jun 13;3(2):88-96. doi: 10.1016/j.pccm.2025.05.002. eCollection 2025 Jun.
2
E3 ligase TRIM22 promotes melanoma proliferation by regulating cell cycle progression through K63-linked ubiquitination of p21.E3 连接酶TRIM22通过对p21进行K63连接的泛素化修饰来调控细胞周期进程,从而促进黑色素瘤的增殖。
Sci Rep. 2025 Jul 1;15(1):22311. doi: 10.1038/s41598-025-06348-4.
3
Sphingosine-1-Phosphate Metabolic Pathway in Cancer: Implications for Therapeutic Targets.

本文引用的文献

1
WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells.WTAP/IGF2BP3介导的EGR1/PTEN轴的m6A修饰调控子宫内膜癌干细胞的恶性表型。
J Exp Clin Cancer Res. 2024 Jul 23;43(1):204. doi: 10.1186/s13046-024-03120-w.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
癌症中的鞘氨醇-1-磷酸代谢途径:对治疗靶点的影响
Int J Mol Sci. 2025 Jan 26;26(3):1056. doi: 10.3390/ijms26031056.
转录组测序分析表明,miR-30c-5p通过靶向METTL3/KRAS轴促进宫颈癌的铁死亡,并抑制宫颈癌异种移植瘤的生长和转移。
Cell Signal. 2024 May;117:111068. doi: 10.1016/j.cellsig.2024.111068. Epub 2024 Jan 27.
4
Non-Lethal Doses of RSL3 Impair Microvascular Endothelial Barrier through Degradation of Sphingosie-1-Phosphate Receptor 1 and Cytoskeletal Arrangement in A Ferroptosis-Independent Manner.非致死剂量的RSL3通过鞘氨醇-1-磷酸受体1的降解和细胞骨架排列以铁死亡非依赖的方式损害微血管内皮屏障。
Biomedicines. 2023 Sep 4;11(9):2451. doi: 10.3390/biomedicines11092451.
5
Identification of key genes in colorectal cancer diagnosis by co-expression analysis weighted gene co-expression network analysis.通过共表达分析加权基因共表达网络分析鉴定结直肠癌诊断中的关键基因。
Comput Biol Med. 2023 May;157:106779. doi: 10.1016/j.compbiomed.2023.106779. Epub 2023 Mar 11.
6
Lung cancer immunotherapy: progress, pitfalls, and promises.肺癌免疫疗法:进展、陷阱和前景。
Mol Cancer. 2023 Feb 21;22(1):40. doi: 10.1186/s12943-023-01740-y.
7
Obesity promotes radioresistance through SERPINE1-mediated aggressiveness and DNA repair of triple-negative breast cancer.肥胖通过 SERPINE1 介导的三阴性乳腺癌侵袭性和 DNA 修复促进放疗抵抗。
Cell Death Dis. 2023 Jan 21;14(1):53. doi: 10.1038/s41419-023-05576-8.
8
SMAD7 and SERPINE1 as novel dynamic network biomarkers detect and regulate the tipping point of TGF-beta induced EMT.SMAD7和SERPINE1作为新型动态网络生物标志物可检测并调节转化生长因子-β诱导的上皮-间质转化的临界点。
Sci Bull (Beijing). 2020 May 30;65(10):842-853. doi: 10.1016/j.scib.2020.01.013. Epub 2020 Jan 16.
9
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
10
MALAT1-miR-30c-5p-CTGF/ATG5 axis regulates silica-induced experimental silicosis by mediating EMT in alveolar epithelial cells.MALAT1-miR-30c-5p-CTGF/ATG5 轴通过调节肺泡上皮细胞 EMT 调控二氧化硅诱导的实验性矽肺。
Ecotoxicol Environ Saf. 2023 Jan 1;249:114392. doi: 10.1016/j.ecoenv.2022.114392. Epub 2022 Dec 9.